2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
复制标题
DOI：
10.1161/cir.0b013e3182051bab
复制
发表时间：
2010-12-21
期刊：
影响因子：
37.8
通讯作者：
Wenger, Nanette K.
中科院分区：
文献类型：
--
作者：
Greenland, Philip;Alpert, Joseph S.;Wenger, Nanette K.
本文件中列出的建议尽可能以证据为基础。对2008年3月至2010年4月期间进行了广泛的证据审查。检索仅限于在人类受试者中进行的研究、评论和其他证据，并以英语发表。关键词包括但不限于：非裔美国人、亚裔美国人、蛋白尿、无症状、无症状筛查和肱动脉反应性、动脉粥样硬化成像、心房颤动、动脉粥样硬化的肱动脉检测、校准、心脏断层扫描、依从性、颈动脉内膜-中膜厚度、冠状动脉钙化、冠状动脉计算机断层扫描血管造影、c反应蛋白（CRP）、亚临床动脉粥样硬化检测、歧视、内皮功能、家族史、血流介导扩张、遗传学、遗传筛查、指南、西班牙裔美国人、血红蛋白A、糖化、meta分析、墨西哥裔美国人、心肌灌注成像（MPI）、无创检测、无创检测和2型糖尿病、结局、患者依从性、外周动脉血压计、外周血压计和动脉粥样硬化、脂蛋白相关磷脂酶A2、冠状动脉疾病一级预防、蛋白尿、心血管风险、风险评分、受试者工作特征曲线、肱动脉反应性筛查、应激超声心动图、亚临床动脉粥样硬化、亚临床和Framingham、亚临床和多民族动脉粥样硬化研究（MESA）和2型
The recommendations listed in this document are, whenever possible, evidence based. An extensive evidence review was conducted for the period beginning March 2008 through April 2010. Searches were limited to studies, reviews, and other evidence conducted in human subjects and published in English. Key search words included, but were not limited to, African Americans, Asian Americans, albuminuria, asymptomatic, asymptomatic screening and brachial artery reactivity, atherosclerosis imaging, atrial fibrillation, brachial artery testing for atherosclerosis, calibration, cardiac tomography, compliance, carotid intima-media thickness, coronary calcium, coronary computed tomography angiography, C-reactive protein (CRP), detection of subclinical atherosclerosis, discrimination, endothelial function, family history, flow-mediated dilation, genetics, genetic screening, guidelines, Hispanic Americans, hemoglobin A, glycosylated, meta-analysis, Mexican Americans, myocardial perfusion imaging (MPI), noninvasive testing, noninvasive testing and type 2 diabetes, outcomes, patient compliance, peripheral arterial tonometry, peripheral tonometry and atherosclerosis, lipoprotein-associated phospholipase A2, primary prevention of coronary artery disease, proteinuria, cardiovascular risk, risk scoring, receiver operating characteristics curve, screening for brachial artery reactivity, stress echocardiography, subclinical atherosclerosis, subclinical and Framingham, subclinical and Multi-Ethnic Study of Atherosclerosis (MESA), and type 2